Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 15;199(2):240-243.
doi: 10.1164/rccm.201807-1279LE.

IL-5 Levels in Nasosorption and Sputosorption Correlate with Sputum Eosinophilia in Allergic Asthma

Affiliations

IL-5 Levels in Nasosorption and Sputosorption Correlate with Sputum Eosinophilia in Allergic Asthma

Jose T Melo Jr et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Sputosorption and nasosorption reveal IL-5 to be selectively increased in the asthmatic airway. (A) Sputum eosinophil levels (left) and nasosorption and sputosorption IL-5 levels (right) in healthy control patients (HCs; n = 17) and patients with asthma (n = 29). Bars represent median and interquartile range. Between-group comparisons by Mann-Whitney U test; ***P < 0.001. (B) Heat map of nasosorption and sputosorption levels of a panel of cytokines and chemokines (IL-5, IL-10, IL-13, tumor necrosis factor-α, CXCL8/IL-8, and CCL11) in HCs and allergic asthmatics (AAs). Mediator levels were normalized (Z scores) and were hierarchically clustered. Levels of mediators between HCs and AAs were compared using Mann-Whitney test and corresponding P values summarized: *P < 0.05; ***P < 0.001. (C) Spearman rank correlations between matched sputosorption and nasosorption samples in HCs and AAs: **P < 0.01; ***P < 0.001.
Figure 2.
Figure 2.
Airway IL-5 levels are closely associated with eosinophilic asthma. (A) Correlation matrix of nasosorption and sputosorption ILs and sputum eosinophils, neutrophils, and macrophages in patients with asthma (n = 29); blank squares denote insignificant correlations; color denotes Spearman R value. (B) Nasosorption IL-5 levels in allergic asthmatics stratified on a 3% cut-off for defining sputum eosinophilia (Eos). (C) Sputosorption IL-5 levels in allergic asthmatics with the 3% threshold for defining sputum eosinophilia. (<3% Eos: n = 13, >3%Eos: n = 16). *P = 0.037; **P = 0.001.

References

    1. Israel E, Reddel HK. Severe and difficult-to-treat asthma in adults. N Engl J Med. 2017;377:965–976. - PubMed
    1. Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, et al. After asthma: redefining airways diseases. Lancet. 2018;391:350–400. - PubMed
    1. Hansel TT, Tunstall T, Trujillo-Torralbo MB, Shamji B, Del-Rosario A, Dhariwal J, et al. A comprehensive evaluation of nasal and bronchial cytokines and chemokines following experimental rhinovirus infection in allergic asthma: increased interferons (IFN-γ and IFN-λ) and type 2 inflammation (IL-5 and IL-13) EBioMedicine. 2017;19:128–138. - PMC - PubMed
    1. Thwaites RS, Jarvis HC, Singh N, Jha A, Pritchard A, Fan H, et al. Absorption of nasal and bronchial fluids: precision sampling of the human respiratory mucosa and laboratory processing of samples J Vis Exp 2018. e56413. - PMC - PubMed
    1. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) Allergy. 2008;63:8–160. - PubMed

Publication types